Once-Monthly Long-Acting Injectable Aripiprazole for the Treatment of Patients with Schizophrenia and Co-occurring Substance Use Disorders: A Multicentre, Observational Study

• मुख्य लेखकों: Nestor Szerman (लेखक), Ignacio Basurte-Villamor (लेखक), Pablo Vega (लेखक), Jose Martinez-Raga (लेखक), Carlos Parro-Torres (लेखक), Julia Cambra Almerge (लेखक), Lara Grau-López (लेखक), Mario De Matteis (लेखक), Francisco Arias (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Adis, Springer Healthcare, 2020-02-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Abstract Aim To evaluate the efficacy and impact of long-acting injectable (LAI) aripiprazole in patients with schizophrenia with a coexisting substance use disorder (SUD). Patients and methods A multicenter, observational, descriptive and retrospective study was conducted in patients with a DSM-5 d...